Literature DB >> 8456286

Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation.

J M Pongubala1, C Van Beveren, S Nagulapalli, M J Klemsz, S R McKercher, R A Maki, M L Atchison.   

Abstract

PU.1 recruits the binding of a second B cell-restricted nuclear factor, NF-EM5, to a DNA site in the immunoglobulin kappa 3' enhancer. DNA binding by NF-EM5 requires a protein-protein interaction with PU.1 and specific DNA contacts. Dephosphorylated PU.1 bound to DNA but did not interact with NF-EM5. Analysis of serine-to-alanine mutations in PU.1 indicated that serine 148 (Ser148) is required for protein-protein interaction. PU.1 produced in bacteria did not interact with NF-EM5. Phosphorylation of bacterially produced PU.1 by purified casein kinase II modified it to a form that interacted with NF-EM5 and that recruited NF-EM5 to bind to DNA. Phosphopeptide analysis of bacterially produced PU.1 suggested that Ser148 is phosphorylated by casein kinase II. This site is also phosphorylated in vivo. Expression of wild-type PU.1 increased expression of a reporter construct containing the PU.1 and NF-EM5 binding sites nearly sixfold, whereas the Ser148 mutant form only weakly activated transcription. These results demonstrate that phosphorylation of PU.1 at Ser148 is necessary for interaction with NF-EM5 and suggest that this phosphorylation can regulate transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8456286     DOI: 10.1126/science.8456286

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  74 in total

1.  Do lampreys have lymphocytes? The Spi evidence.

Authors:  S Shintani; J Terzic; A Sato; M Saraga-Babic; C O'hUigin; H Tichy; J Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

2.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Mutants of ETS domain PU.1 and GGAA/T recognition: free energies and kinetics.

Authors:  F Pio; N Assa-Munt; J Yguerabide; R A Maki
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

4.  Mutation analysis of the Pip interaction domain reveals critical residues for protein-protein interactions.

Authors:  M A Ortiz; J Light; R A Maki; N Assa-Munt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.

Authors:  A L Brass; A Q Zhu; H Singh
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

6.  DNA binding and transcription activation by chicken interferon regulatory factor-3 (chIRF-3).

Authors:  C E Grant; D L May; R G Deeley
Journal:  Nucleic Acids Res       Date:  2000-12-01       Impact factor: 16.971

7.  Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1.

Authors:  Jynho Kim; Ricardo A Feldman
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

8.  Methylation of an ETS site in the intron enhancer of the keratin 18 gene participates in tissue-specific repression.

Authors:  A Umezawa; H Yamamoto; K Rhodes; M J Klemsz; R A Maki; R G Oshima
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 9.  Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis.

Authors:  Natasza A Kurpios; Nancy A Sabolic; Trevor G Shepherd; Gina M Fidalgo; John A Hassell
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

10.  Identification of a PU.1-IRF4 protein interaction surface predicted by chemical exchange line broadening.

Authors:  Scott R McKercher; Christian R Lombardo; Andrey Bobkov; Xin Jia; Nuria Assa-Munt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.